Valuation: Eckert & Ziegler SE

Market Cap 83Cr 93Cr 77Cr 69Cr 129.66Cr 8.82TCr 132.09Cr 912.94Cr 366.48Cr 4.64TCr 348.75Cr 341.34Cr 15TCr P/E 2026 *
16.3x
P/E 2027 * 15.4x
Enterprise Value 72Cr 80Cr 66Cr 60Cr 111.63Cr 7.6TCr 113.72Cr 785.95Cr 315.51Cr 4TCr 300.24Cr 293.86Cr 13TCr EV / Sales 2026 *
2.25x
EV / Sales 2027 * 2.08x
Free-Float
67.36%
Yield 2026 *
1.58%
Yield 2027 * 1.62%
1 day+0.61%
1 week+1.76%
Current month+4.40%
1 month+4.40%
3 months-3.97%
6 months-12.84%
Current year-12.84%
1 week 12.52
Extreme 12.52
13.55
1 month 11.91
Extreme 11.91
13.55
Current year 11.91
Extreme 11.91
16.84
1 year 11.91
Extreme 11.91
17.47
3 years 10.91
Extreme 10.913333
23.25
5 years 9.64
Extreme 9.639999
46.8
10 years 1.74
Extreme 1.740416
47.13
Manager TitleAgeSince
Chief Executive Officer 59 07/06/2023
Chief Tech/Sci/R&D Officer - 01/01/2025
Chief Operating Officer 59 01/01/2025
Director TitleAgeSince
Chairman 57 07/06/2023
Director/Board Member 66 01/01/2014
Director/Board Member 58 01/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
26/03/24 Sell

Founder

6,720 0.0317%
26/03/24 Buy

Founder

6,720 0.0317%
30/08/23 Sell

Founder

48,000 0.2267%
Change 5-day change 1-year change 3-year change Capi.($)
+0.61%+1.76%-21.76%+9.92% 93Cr
-1.72%+3.44%+25.31%+60.56% 26TCr
-2.00%+0.75%+7.99%+25.46% 16TCr
-3.73%-4.48%-18.49%+67.13% 15TCr
-1.66%-8.12%-58.26%-16.12% 6.08TCr
-2.57%+3.30%+10.22%+47.55% 5.3TCr
0.00%+2.46%-11.97%-6.29% 5.33TCr
-3.47%+1.04%+21.98%+72.85% 4.93TCr
+0.84%-3.12%+9.80%+64.47% 5.07TCr
-3.61%+1.99%+34.94%+95.49% 4.55TCr
Average -1.73%-0.10%-0.02%+42.10% 8.84TCr
Weighted average by Cap. -2.10%+0.15%+5.16%+47.75%

Financials

2026 *2027 *
Net sales 32Cr 36Cr 29Cr 27Cr 50Cr 3.37TCr 50Cr 348.81Cr 140.02Cr 1.77TCr 133.25Cr 130.41Cr 5.59TCr 34Cr 38Cr 31Cr 28Cr 53Cr 3.62TCr 54Cr 374.94Cr 150.51Cr 1.91TCr 143.23Cr 140.19Cr 6.01TCr
Net income 5.17Cr 5.77Cr 4.75Cr 4.31Cr 8.05Cr 547.91Cr 8.2Cr 57Cr 23Cr 288.21Cr 22Cr 21Cr 908.92Cr 5.31Cr 5.93Cr 4.88Cr 4.42Cr 8.27Cr 562.8Cr 8.43Cr 58Cr 23Cr 296.05Cr 22Cr 22Cr 933.63Cr
Net Debt -12Cr -13Cr -11Cr -9.65Cr -18Cr -1.23TCr -18Cr -126.98Cr -51Cr -645.6Cr -49Cr -47Cr -2.04TCr -12Cr -14Cr -11Cr -10Cr -19Cr -1.3TCr -19Cr -134.38Cr -54Cr -683.18Cr -51Cr -50Cr -2.15TCr
Projected Income Statement - Annual - Eckert & Ziegler SE
Logo Eckert & Ziegler SE
Eckert & Ziegler SE is a Germany-based Company, which is a provider of isotope technology for medical, scientific and industrial use with focus on cancer therapy, industrial radiometry and nuclear-medical imaging. The Company operates through three segments: Radiation Therapy, Isotope Products and Radiopharma. The Radiation Therapy segment operates through Eckert & Ziegler BEBIG and produces and distributes medical products for the treatment of cancer using brachytherapy. The Isotope Products segment provides sealed and unsealed radiation sources for medical imaging, industrial gauging, measurement and analysis, reference, calibration and environmental monitoring sources and solutions, as well as bulk radioisotopes for pharmaceutical, therapeutic and industrial product manufacturers. The Radiopharma segment specializes in molecular imaging and nuclear medicine, and supplies various radiopharmaceuticals, radiochemicals and related equipment.
Employees
1,105
Date Price Change Volume
30/26/30 €13.30 +0.61% 93,765
29/26/29 €13.22 -0.60% 81,429
28/26/28 €13.30 +2.39% 1,31,994
27/26/27 €12.99 +0.85% 95,394
26/26/26 €12.88 -1.45% 1,09,530
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Eckert & Ziegler SE
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
13.30EUR
Average target price
21.60EUR
Spread / Average Target
+62.41%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Eckert & Ziegler SE